Please login to the form below

Not currently logged in

Global consortium of medicines regulators reveals new strategic plan

Access Consortium includes regulators from Australia, Canada, Singapore, Switzerland and the UK

A consortium of five medicines regulators has published its strategic plan for the next three years to provide faster access to medicines by aligning regulation and policies.

The Access Consortium is a collaborative initiative uniting medicines regulators from Australia, Canada, Singapore, Switzerland and the UK.

Initially, the group consisted of regulatory authorities from Australia, Canada, Singapore and Switzerland, with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) joining in October 2020.

The MHRA is also part of another group of regulators – some of which overlap with the Access Consortium – called Project Orbis. This programme includes regulators from Canada, Australia, Switzerland, Singapore, the UK, Brazil and other countries, and is coordinated by the US Food and Drug Administration (FDA).

Collectively, the Access Consortium represents a total population base of 150 million, according to its recently published strategy.

Among its strategic objectives for 2021-2024 is an aim to strengthen access work-sharing initiatives, by increasing the number of applications and increasing the variety of health products assessed collectively.

The consortium will also work to improve the work-sharing processes through the lessons learned from the COVID-19 pandemic.

In addition, the consortium is aiming to expand the life cycle approach by maximising collaboration through the use of real-world data and real-world evidence in clinical trial design and regulatory approaches.

To ensure the uptake of innovative health products, the consortium hopes to increase regulatory capacity while collaborating with key national healthcare systems partners.

Article by
Lucy Parsons

23rd June 2021

From: Regulatory



Subscribe to our email news alerts

Featured jobs


Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...